全文获取类型
收费全文 | 19550篇 |
免费 | 1495篇 |
国内免费 | 1091篇 |
出版年
2024年 | 55篇 |
2023年 | 229篇 |
2022年 | 594篇 |
2021年 | 926篇 |
2020年 | 610篇 |
2019年 | 756篇 |
2018年 | 834篇 |
2017年 | 556篇 |
2016年 | 854篇 |
2015年 | 1160篇 |
2014年 | 1320篇 |
2013年 | 1477篇 |
2012年 | 1782篇 |
2011年 | 1563篇 |
2010年 | 971篇 |
2009年 | 852篇 |
2008年 | 1073篇 |
2007年 | 935篇 |
2006年 | 827篇 |
2005年 | 736篇 |
2004年 | 585篇 |
2003年 | 551篇 |
2002年 | 474篇 |
2001年 | 357篇 |
2000年 | 295篇 |
1999年 | 288篇 |
1998年 | 180篇 |
1997年 | 137篇 |
1996年 | 105篇 |
1995年 | 111篇 |
1994年 | 79篇 |
1993年 | 70篇 |
1992年 | 96篇 |
1991年 | 96篇 |
1990年 | 87篇 |
1989年 | 68篇 |
1988年 | 56篇 |
1987年 | 53篇 |
1986年 | 39篇 |
1985年 | 44篇 |
1984年 | 23篇 |
1983年 | 23篇 |
1982年 | 21篇 |
1981年 | 13篇 |
1979年 | 20篇 |
1978年 | 16篇 |
1977年 | 19篇 |
1976年 | 15篇 |
1975年 | 14篇 |
1972年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 17 毫秒
911.
Jin Zhao Jiaoshan Chen Congcong Wang Yajie Liu Minchao Li Yanjun Li Ruiting Li Zirong Han Junjian Wang Ling Chen Yuelong Shu Genhong Cheng Caijun Sun 《PLoS pathogens》2022,18(3)
Tryptophan (Trp) metabolism through the kynurenine pathway (KP) is well known to play a critical function in cancer, autoimmune and neurodegenerative diseases. However, its role in host-pathogen interactions has not been characterized yet. Herein, we identified that kynurenine-3-monooxygenase (KMO), a key rate-limiting enzyme in the KP, and quinolinic acid (QUIN), a key enzymatic product of KMO enzyme, exerted a novel antiviral function against a broad range of viruses. Mechanistically, QUIN induced the production of type I interferon (IFN-I) via activating the N-methyl-d-aspartate receptor (NMDAR) and Ca2+ influx to activate Calcium/calmodulin-dependent protein kinase II (CaMKII)/interferon regulatory factor 3 (IRF3). Importantly, QUIN treatment effectively inhibited viral infections and alleviated disease progression in mice. Furthermore, kmo-/- mice were vulnerable to pathogenic viral challenge with severe clinical symptoms. Collectively, our results demonstrated that KMO and its enzymatic product QUIN were potential therapeutics against emerging pathogenic viruses. 相似文献
912.
913.
Xiaoxu Cui Chengyu Hao Lijing Gong Naoko Kajitani Stefan Schwartz 《Nucleic acids research》2022,50(5):2782
Human papillomavirus type 16 (HPV16) E1 and E6 proteins are produced from mRNAs with retained introns, but it has been unclear how these mRNAs are generated. Here, we report that hnRNP D act as a splicing inhibitor of HPV16 E1/E2- and E6/E7-mRNAs thereby generating intron-containing E1- and E6-mRNAs, respectively. N- and C-termini of hnRNP D contributed to HPV16 mRNA splicing control differently. HnRNP D interacted with the components of splicing machinery and with HPV16 RNA to exert its inhibitory function. As a result, the cytoplasmic levels of intron-retained HPV16 mRNAs were increased in the presence of hnRNP D. Association of hnRNP D with HPV16 mRNAs in the cytoplasm was observed, and this may correlate with unexpected inhibition of HPV16 E1- and E6-mRNA translation. Notably, hnRNP D40 interacted with HPV16 mRNAs in an HPV16-driven tonsillar cancer cell line and in HPV16-immortalized human keratinocytes. Furthermore, knockdown of hnRNP D in HPV16-driven cervical cancer cells enhanced production of the HPV16 E7 oncoprotein. Our results suggest that hnRNP D plays significant roles in the regulation of HPV gene expression and HPV-associated cancer development. 相似文献
914.
Hanlin Ma Gonghua Qi Fang Han Wei Lu Jiali Peng Rongrong Li Shi Yan Cunzhong Yuan Beihua Kong 《Cell death & disease》2022,13(3)
Poly (ADP-ribose) polymerase (PARP) inhibitor (PARPi) resistance remains a therapeutic challenge in ovarian cancer. High-mobility group box 3 (HMGB3) plays significant roles in the development of drug resistance of many cancers. However, the function of HMGB3 in PARPi resistance is poorly understood. In the current study, we clarified that HMGB3 was aberrantly overexpressed in high-grade serous ovarian carcinoma (HGSOC) tissues, and high HMGB3 levels indicated shorter overall survival and drug resistance in HGSOC. The overexpression of HMGB3 increased the insensitivity of ovarian cancer to PARPi, whereas HMGB3 knockdown reduced PARPi resistance. Mechanistically, PARP1 was identified as a novel interaction partner of HMGB3, which could be blocked using olaparib and was enhanced upon DNA damage conditions. We further showed that loss of HMGB3 induced PARP1 trapping at DNA lesions and inhibited the PARylation activity of PARP1, resulting in an increased DNA damage response and cell apoptosis. The PARPi-resistant role of HMGB3 was also verified in a xenograft mouse model. In conclusion, HMGB3 promoted PARPi resistance via interacting with PARP1, and the targeted inhibition of HMGB3 might overcome PARPi resistance in ovarian cancer therapy.Subject terms: Chemotherapy, Ovarian cancer, Ovarian cancer, Cancer therapeutic resistance 相似文献
915.
In this study,a human-chair model was developed as the basis for a wearable-chair design.Aprototype chair,HUST-EC,based on the model was fabricated and evaluate... 相似文献
916.
917.
918.
Yinzhu Hou Tieliang Gan Tiantian Fang Yao Zhao Qun Luo Xingkai Liu Luyu Qi Yanyan Zhang Feifei Jia Juanjuan Han Shumu Li Shijun Wang Fuyi Wang 《Nucleic acids research》2022,50(6):3070
Pyridostatin (PDS) is a well-known G-quadruplex (G4) inducer and stabilizer, yet its target genes have remained unclear. Herein, applying MS proteomics strategy, we revealed PDS significantly downregulated 22 proteins but upregulated 16 proteins in HeLa cancer cells, of which the genes both contain a number of G4 potential sequences, implying that PDS regulation on gene expression is far more complicated than inducing/stabilizing G4 structures. The PDS-downregulated proteins consequently upregulated 6 proteins to activate cyclin and cell cycle regulation, suggesting that PDS itself is not a potential anticancer agent, at least toward HeLa cancer cells. Importantly, SUB1, which encodes human positive cofactor and DNA lesion sensor PC4, was downregulated by 4.76-fold. Further studies demonstrated that the downregulation of PC4 dramatically promoted the cytotoxicity of trans-[PtCl2(NH3)(thiazole)] (trans-PtTz) toward HeLa cells to a similar level of cisplatin, contributable to retarding the repair of 1,3-trans-PtTz crosslinked DNA lesion mediated by PC4. These findings not only provide new insights into better understanding on the biological functions of PDS but also implicate a strategy for the rational design of novel multi-targeting platinum anticancer drugs via conjugation of PDS as a ligand to the coordination scaffold of transplatin for battling drug resistance to cisplatin. 相似文献
919.
Shuangze Han Ruike Wang Yangnan Zhang Xiaoying Li Yu Gan Feng Gao Pengfei Rong Wei Wang Wei Li 《International journal of biological sciences》2022,18(6):2292
Ubiquitination is vital for multiple cellular processes via dynamic modulation of proteins related to cell growth, proliferation, and survival. Of the ubiquitination system components, E3 ubiquitin ligases and deubiquitinases have the most prominent roles in modulating tumor metastasis. This review will briefly summarize the observations and underlying mechanisms of multiple E3 ubiquitin ligases and deubiquitinases to regulate tumor metastasis. Further, we will discuss the relationship and importance between ubiquitination components and tumor progression. 相似文献
920.
Seungyeon Ryu Myeongwoo Jung Chongtae Kim Hoin Kang Sukyoung Han Seongho Cha Seung Min Jeong Eun Kyung Lee 《Cell death & disease》2022,13(4)
HuD, an RNA binding protein, plays a role in the regulation of gene expression in certain types of cells, including neuronal cells and pancreatic β-cells, via RNA metabolism. Its aberrant expression is associated with the pathogenesis of several human diseases. To explore HuD-mediated gene regulation, stable cells expressing short hairpin RNA against HuD were established using mouse neuroblastoma Neuro2a (N2a) cells, which displayed enhanced phenotypic characteristics of cellular senescence. Two approaches, RNA immunoprecipitation (RNA IP)-NanoString profiling and cytokine array, were used to subsequently identify a subset of putative HuD targets that act as senescence-associated secretory phenotype (SASP), including C-C motif ligand 2 (CCL2), CCL20, C-X-C motif chemokine ligand 2 (CXCL2), and interleukin-6 (IL-6). Here, we further demonstrated that HuD regulates the expression of CCL2, a SASP candidate upregulated in cells following HuD knockdown, by binding to the 3′-untranslated region (UTR) of Ccl2 mRNA. Downregulation of HuD increased the level of CCL2 in N2a cells and the brain tissues of HuD knockout (KO) mice. Exposure to γ-irradiation induced cellular senescence in N2a cells and HuD knockdown facilitated stress-induced cellular senescence. Our results reveal that HuD acts as a novel regulator of CCL2 expression, and its aberrant expression may contribute to cellular senescence by regulating SASP production.Subject terms: Senescence, RNA quality control 相似文献